Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Go back to Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products| (NASDAQ: KALA) | Delayed: 0.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.36 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $ | |||
| Volume | 1,720 | |||||



